Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Corticotropin ; related peptides
Patent
1995-12-19
1998-12-01
Tsang, Cecilia J.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Corticotropin ; related peptides
530317, 930 21, 930 70, 930260, 514 9, 514 2, 514805, A61K 3828, A61K 3812, C07K 14695, C07K 764
Patent
active
058440747
ABSTRACT:
Novel cyclic CRF agonist peptides have the amino acid sequence: (cyclo 30-33)Ac-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu -Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-R.sub.30 -Ala-R.sub.32 -R.sub.33 -Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH.sub.2 wherein R.sub.30 is Glu or Cys; R.sub.32 is His or a D-amino acid such as D-His, D-Arg or similar; R.sub.33 is Lys, Orn or Cys. The N-terminus may be extended by Ser-Glu-Glu. Lys may be substituted for Arg.sup.23, and its side chain connected by a lactam bridge to Glu.sup.20 to form a bicyclic peptide. Certain disclosed CRF agonists include: Glu.sup.30, Lys.sup.33 !r/hCRF(4-41), Glu.sup.30, Orn.sup.33 !r/hCRF(4-41), D-His.sup.32 !r/hCRF(4-41), Lys.sup.23,33, Glu.sup.30, D-His.sup.32 !-r/hCRF(4-41), Glu.sup.30, imBzlD-His.sup.32, Lys.sup.33 !r/hCRF(4-41) and D-Arg.sup.32, Lys.sup.33 !r/hCRF(4-41). Nle.sup.21,38, Glu.sup.30, D-His.sup.32, Lys.sup.33 !r/hCRF and (cyclo D-His.sup.32, Lys.sup.33 !r/hCRF(3-41) are useful in screening for more potent agonists.
REFERENCES:
patent: 5439885 (1995-08-01), Kornreich et al.
patent: 5493006 (1996-02-01), de Miranda et al.
Gulyas et al., "Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor", P.N.A.S., vol. 92, pp. 10575-10579 (Nov. 1995).
Miranda, A. et al. Conformationally restricted competitive a factor. J. Med. Chem. 37, 1450-1459, Oct. 1994.
Borin Michael
The Salk Institute for Biological Studies
Tsang Cecilia J.
LandOfFree
Cyclic CRF agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic CRF agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic CRF agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396544